Drugs for AIDS and associated infections.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D053626:Atovaquone; D002180:Candidiasis, Oral / Q000188:drug therapy*; D002981:Clindamycin / Q000627:therapeutic use; D003022:Clotrimazole / Q000627:therapeutic use; D003457:Cryptosporidiosis / Q000188:drug therapy*; D003586:Cytomegalovirus Infections / Q000188:drug therapy*; D003622:Dapsone / Q000627:therapeutic use; D016049:Didanosine / Q000627:therapeutic use; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D015725:Fluconazole / Q000627:therapeutic use; D005437:Flucytosine / Q000627:therapeutic use; D005493:Folic Acid Antagonists / Q000627:therapeutic use; D017245:Foscarnet / Q000627:therapeutic use; D005965:Glucuronates / Q000627:therapeutic use; D006561:Herpes Simplex / Q000188:drug therapy*; D006562:Herpes Zoster / Q000188:drug therapy; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D017964:Itraconazole / Q000627:therapeutic use; D007654:Ketoconazole / Q000627:therapeutic use; D019259:Lamivudine; D015270:Mycobacterium avium-intracellulare Infection / Q000188:drug therapy*; D009285:Naphthoquinones / Q000627:therapeutic use; D009761:Nystatin / Q000627:therapeutic use; D010419:Pentamidine / Q000627:therapeutic use; D016720:Pneumocystis Infections / Q000188:drug therapy*; D011020:Pneumonia, Pneumocystis / Q000188:drug therapy; D011241:Prednisone / Q000627:therapeutic use; D011319:Primaquine / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D018119:Stavudine / Q000627:therapeutic use; D013587:Syphilis / Q000188:drug therapy*; D014123:Toxoplasmosis / Q000188:drug therapy* / Q000517:prevention & control; D016597:Trimetrexate / Q000031:analogs & derivatives / Q000627:therapeutic use; D014376:Tuberculosis / Q000188:drug therapy* / Q000517:prevention & control; D016047:Zalcitabine / Q000031:analogs & derivatives / Q000627:therapeutic use; D015215:Zidovudine / Q000009:adverse effects / Q000627:therapeutic use
D000935:Antifungal Agents; D000981:Antiprotozoal Agents; D000998:Antiviral Agents; D004338:Drug Combinations; D005493:Folic Acid Antagonists; D005965:Glucuronates; D009285:Naphthoquinones; D018894:Reverse Transcriptase Inhibitors; D009761:Nystatin; D019259:Lamivudine; D017964:Itraconazole; D017245:Foscarnet; D002981:Clindamycin; D015215:Zidovudine; D010419:Pentamidine; D016047:Zalcitabine; D000666:Amphotericin B; D015725:Fluconazole; D003622:Dapsone; D018119:Stavudine; D005437:Flucytosine; D003022:Clotrimazole; D016049:Didanosine; C056321:trimetrexate glucuronate; D011319:Primaquine; D007654:Ketoconazole; D016597:Trimetrexate; D007538:Isoniazid; D011241:Prednisone; D053626:Atovaquone